Literature DB >> 43367

The effects of bromocriptine on pre-synaptic and post-synaptic alpha-adrenoceptors in the mouse vas deferens.

A Gibson, M Samini.   

Abstract

Noradrenaline (NA) and dopamine (DA) contracted the mouse vas deferens and reduced the responses to low frequency nerve stimulation (0.1 Hz). The relative potencies of antagonists suggested that these effects were due to stimulation of post-synaptic and pre-synaptic alpha-adrenoceptors respectively. Bromocriptine produced a non-competitive antagonism of contractile responses to NA (pD2' = 7.6) and DA (pD2' = 8.0) but had no effect on responses to carbachol. Bromocriptine also reduced single twitch responses of the vas to low frequency field stimulation (0.1 Hz), but did not affect stimulation at higher frequencies (1--20 Hz). Yohimbine selectively and rapidly reversed the inhibiting effects of bromocriptine on single twitches, although they could not easily be reversed by washing. Bromocriptine produced a yohimbine-reversible reduction in the stimulated overflow of tritium from vasa previously loaded with 3H--NA. Thus the mouse vas deferens does not appear to contain specific DA receptors and the results suggest that bromocriptine acts as a pre-synaptic alpha-adrenoceptor agonist and post-synaptic alpha-adrenoceptor antagonist in this tissue.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43367     DOI: 10.1111/j.2042-7158.1979.tb13674.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

1.  A dose rising study of the safety and effects on serum prolactin of SK&F 101468, a novel dopamine D2-receptor agonist.

Authors:  G Acton; C Broom
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

2.  An examination of the putative sigma-receptor in the mouse isolated vas deferens.

Authors:  C Kennedy; G Henderson
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Effects of the dopaminergic agonist cianergoline on blood pressure, the renin-angiotensin-aldosterone axis and the sympathetic nervous system in patients with essential hypertension.

Authors:  G Bise; C Foletti; C Beretta-Piccoli; P Weidmann; W H Ziegler; R Mordasini; C Bachmann
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Dopamine binds to alpha(2)-adrenergic receptors in the song control system of zebra finches (Taeniopygia guttata).

Authors:  Charlotte A Cornil; Christina B Castelino; Gregory F Ball
Journal:  J Chem Neuroanat       Date:  2007-11-04       Impact factor: 3.052

5.  Synergistically acting agonists and antagonists of G protein-coupled receptors prevent photoreceptor cell degeneration.

Authors:  Yu Chen; Grazyna Palczewska; Ikuo Masuho; Songqi Gao; Hui Jin; Zhiqian Dong; Linn Gieser; Matthew J Brooks; Philip D Kiser; Timothy S Kern; Kirill A Martemyanov; Anand Swaroop; Krzysztof Palczewski
Journal:  Sci Signal       Date:  2016-07-26       Impact factor: 8.192

6.  Effect of metoclopramide in guinea-pig ileum longitudinal muscle: evidence against dopamine-mediation.

Authors:  M A Zar; O Ebong; D N Bateman
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

7.  Interplay among catecholamine systems: dopamine binds to alpha2-adrenergic receptors in birds and mammals.

Authors:  Charlotte A Cornil; Gregory F Ball
Journal:  J Comp Neurol       Date:  2008-12-10       Impact factor: 3.215

8.  Contrasting effects of bromocriptine on learning of a partially baited radial arm maze task in the presence and absence of restraint stress.

Authors:  B N Srikumar; T R Raju; B S Shankaranarayana Rao
Journal:  Psychopharmacology (Berl)       Date:  2007-04-28       Impact factor: 4.415

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.